Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

Summary

The goal of this clinical research study is to find the highest tolerable dose of OPB-31121 that can be given to patients with leukemia or myelodysplastic syndrome (MDS).

Timeline

Start

2008-07

Primary completion

2011-08

Completion

2011-08

Outcome

Outcome not reported

Stopped (Business): “Colloborator-Sponsor decision to terminate.”

Drugs

Indications